Long double-stranded multiplex siRNAs for dual genes silencing

Area of Science:

• Molecular Biology
• Cancer Therapeutics
• RNA Interference

Background:

• Simultaneous suppression of multiple oncogenes is a key strategy for effective cancer treatment.
• Developing safe and effective RNA interference (RNAi) therapies requires overcoming challenges like immune response induction and off-target effects.

Purpose of the Study:

• To design and evaluate novel long double-stranded multiplex small interfering RNAs (multi-siRNAs) for simultaneous dual gene silencing.
• To investigate the role of a specific structural gap feature in multi-siRNAs for enhancing gene silencing and minimizing immune responses.
• To assess the therapeutic potential of multi-siRNAs targeting SURVIVIN and BCL-2 in bladder cancer.

Main Methods:

• Synthesis of long double-stranded multiplex small interfering RNAs (multi-siRNAs) with a designed gap feature.
• Evaluation of gene silencing efficacy against SURVIVIN and BCL-2 oncogenes.
• Assessment of immune response induction and impact on bladder cancer cell proliferation and apoptosis.

Main Results:

• The designed gap feature in multi-siRNAs was essential for effective target gene silencing and avoidance of significant immune responses.
• Multi-siRNAs demonstrated effective silencing of SURVIVIN and BCL-2.
• Silencing led to increased caspase-3 mediated apoptosis and subsequent inhibition of bladder cancer cell proliferation.

Conclusions:

• Rationally designed multi-siRNAs with a gap feature offer a promising approach for simultaneous oncogene suppression.
• This strategy effectively inhibits bladder cancer cell proliferation through apoptosis induction.
• The findings support the potential of these multi-siRNAs for future therapeutic applications in cancer treatment.